Fexuprazan to prevent stomach bleeding in heart patients on two blood thinners
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether fexuprazan can prevent upper gastrointestinal bleeding in people at high risk who need two antiplatelet drugs for at least 6 months after a heart stent. If you are on dual antiplatelet therapy after a stent and have risk factors like older age, low weight, or history of ulcers, this study may help protect your stomach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 20 years or older and had a heart stent placed, needing two blood thinners for at least 6 months.
- You are at high risk for stomach bleeding (e.g., age 65+, low body weight, low red blood cells, low platelets, kidney problems, taking blood thinners or NSAIDs long-term, history of stomach ulcers or bleeding, or H. pylori infection).
- You agree to use effective birth control during the study (e.g., IUD, condoms, implants) and cannot use oral contraceptives.
- You do not have severe health issues like active cancer, serious liver disease, severe anemia, or kidney failure requiring dialysis.
- You are not pregnant, breastfeeding, or planning pregnancy, and can follow study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a shorter, gentler blood thinner plan after getting a heart stent. It is designed for people who have had a heart attack or unstable angina and who are at higher risk of bleeding, to help prevent future heart problems with less bleeding risk.
This study aims to improve how doctors monitor and guide treatment for people with heart disease who have had a stent placed. It focuses on finding the best ways to manage blood-thinning medications to reduce risks of bleeding and clotting.
This trial tests a new medicine, fexuprazan, to see if it can prevent stomach ulcers caused by taking NSAID pain relievers for a long time. If you need daily NSAIDs for arthritis or other muscle/bone pain, this medicine might help protect your stomach.
This trial tests if a new stomach acid medicine (Zastaprazan) affects how well clopidogrel works in heart patients who have had a stent placed. It aims to help people who need both clopidogrel and a stomach acid drug after a procedure.
This study watches patients with acute or chronic gastritis who are already being prescribed the stomach medicine Fexuclu (fexuprazan). It collects information to see how well the medicine works and if it causes any side effects in everyday use.
This trial tests a new medicine called zastaprazan, which helps reduce stomach acid, to see if it can prevent bleeding in the stomach and intestines for people who are on blood thinners after a stroke. If you are taking blood thinners, this medicine might lower your risk of serious stomach bleeding.
Hear when a new Acute Coronary Syndromes (ACS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.